nialamide has been researched along with Idiopathic Parkinson Disease in 5 studies
Nialamide: An MAO inhibitor that is used as an antidepressive agent.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schmutzler, F | 1 |
| Eichhorn, A | 1 |
| Petelin, LS | 1 |
| Tret'iakova, KA | 1 |
| Pigarev, VA | 1 |
| Romenskaia, LK | 1 |
| Farnebo, LO | 1 |
| Fuxe, K | 1 |
| Goldstein, M | 1 |
| Hamberger, B | 1 |
| Ungerstedt, U | 1 |
| De la Torre, JC | 1 |
| Mullan, S | 1 |
| Dandiya, PC | 1 |
| Bhargava, LP | 1 |
1 review available for nialamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Antiparkinson agents. 50].
Topics: Atropine; Dihydroxyphenylalanine; Diphenhydramine; Histamine H1 Antagonists; Humans; Mephenesin; Mon | 1970 |
4 other studies available for nialamide and Idiopathic Parkinson Disease
| Article | Year |
|---|---|
[Pathochemical bases for the treatment of parkinsonism].
Topics: Adult; Aged; Antiparkinson Agents; Catecholamines; Dihydroxyphenylalanine; Female; Humans; Male; Mid | 1971 |
Dopamine and noradrenaline releasing action of amantadine in the central and peripheral nervous system: a possible mode of action in Parkinson's disease.
Topics: Amantadine; Animals; Catecholamines; Central Nervous System; Dopamine; Electrocoagulation; Hindlimb; | 1971 |
Experimental evaluation of L-dopa penetration in brain.
Topics: Blood-Brain Barrier; Brain; Carboxy-Lyases; Dihydroxyphenylalanine; Dopamine; Drug Synergism; Humans | 1971 |
The antiparkinsonian activity of monoamine oxidase inhibitors and other agents in rats and mice.
Topics: Animals; Dextroamphetamine; Diphenhydramine; Imipramine; Iproniazid; Isocarboxazid; Mice; Monoamine | 1968 |